These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 14633140
21. Role of macula densa cyclooxygenase-2 in renovascular hypertension. Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF. Am J Physiol Renal Physiol; 2003 Mar; 284(3):F498-502. PubMed ID: 12429553 [Abstract] [Full Text] [Related]
22. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Wallace JL, McKnight W, Reuter BK, Vergnolle N. Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765 [Abstract] [Full Text] [Related]
23. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270 [Abstract] [Full Text] [Related]
24. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors. Berenguer B, Alarcón de la Lastra C, Moreno FJ, Martín MJ. Eur J Pharmacol; 2002 May 03; 442(1-2):125-35. PubMed ID: 12020690 [Abstract] [Full Text] [Related]
25. [Renal tolerance of selective inhibitors of cyclooxygenase type 2]. Deray G. Presse Med; 2001 Oct 20; 30(30):1507-12. PubMed ID: 11712212 [Abstract] [Full Text] [Related]
26. COX-2 inhibition and prostaglandin receptors in experimental nephritis. Waldner C, Heise G, Schrör K, Heering P. Eur J Clin Invest; 2003 Nov 20; 33(11):969-75. PubMed ID: 14636300 [Abstract] [Full Text] [Related]
27. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient]. Galli G, Panzetta G. G Ital Nefrol; 2002 Nov 20; 19(2):199-203. PubMed ID: 12195419 [Abstract] [Full Text] [Related]
28. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G. FASEB J; 2001 Dec 20; 15(14):2742-4. PubMed ID: 11606477 [Abstract] [Full Text] [Related]
29. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Clin Pharmacol Ther; 1999 Jul 20; 66(1):76-84. PubMed ID: 10430112 [Abstract] [Full Text] [Related]
31. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS. J Rheumatol Suppl; 1999 Apr 20; 56():31-6. PubMed ID: 10225538 [Abstract] [Full Text] [Related]